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Global Bang for the Buck
Cutting Black Carbon and Methane Benefits 
Both Health and Climate
Black carbon and methane have both been implicated in climate 
change. They also pose more direct human health threats, with 
black carbon constituting one component of fine particulate matter 
(PM2.5) and methane acting as a precursor of ground-level ozone. An 
international team of researchers analyzed 14 control measures for 
human-caused emissions of black carbon and methane to investigate 
health benefits that might occur in tandem with actions to help miti-
gate climate change in the next 20–40 years [EHP 120(6):831–839; 
Anenberg et al.]. 
Black carbon and methane are attractive climate-change mitiga-
tion targets because they are relatively short-lived in the atmosphere 
compared with carbon dioxide, with emission restrictions leading to 
fairly rapid benefits. Some of the primary sources of methane are fossil-
fuel extraction, landfills, livestock, rice production, and wastewater 
treatment. Among major sources of black carbon are many types of 
incomplete combustion, including that tied to transportation, industry, 
housing, and burning of biomass. The 14 measures target sources 
such as fossil-fuel operations, vehicle emissions, landfill gas, sewage, 
agriculture, brick kilns, and biomass-fueled cook stoves. 
Using published emissions scenarios as a basis for their calcula-
tions, the investigators estimate that if all 14 measures were fully 
implemented by 2030, average global population-weighted surface 
concentrations of PM2.5 could be reduced by 23–34% and ozone could 
drop 7–17% within the same period. That could prevent anywhere 
from 640,000 to 4,900,000 premature deaths annually, or about 1–7% 
of all deaths estimated to occur with the projected global population of 
8.4 billion. The estimated health benefits would be due almost entirely 
to the black carbon control measures—with their attendant reductions 
in PM2.5, organic carbon, and non-methane ozone precursors—and 
would occur mostly in Asia and portions of Africa. Climate-change 
mitigation effects could have their own health benefits, although the 
authors didn’t attempt to calculate these. The authors accounted for 
just outdoor exposures from biomass-fueled cook stoves, not the well-
documented health benefits of avoided indoor exposures; adding that 
information with a geographically appropriate distribution likely would 
substantially increase the number of avoided premature deaths.
The researchers used two atmospheric models, each of which pre-
dicted substantially different air-quality responses to the 14 measures 
and incorporated a wide range of data from numerous epidemiological 
studies as factors in their equations. Uncertainties and variations in the 
models and data suggest the number of averted premature deaths could 
be substantially higher or lower. The researchers didn’t address the 
difficulties or costs of implementing the 14 measures but did note that 
some related efforts are already under way on many continents, includ-
ing adoption of European vehicle-emission standards and reductions in 
cook-stove emissions in some developing countries.
Bob Weinhold, MA, has covered environmental health issues for numerous outlets since 1996. 
He is a member of the Society of Environmental Journalists.
A Compact Exposure
Estimating Inhalation of Engineered 
Nanoparticles in Cosmetic Powders  
The growing use of engineered nanomaterials in consumer products 
raises questions regarding potential adverse health effects of nano-
material exposures. Although a considerable amount of research exists 
on the toxicity of pure nanomaterials, there is only limited informa-
tion exposure to nano  materials 
combined with other ingre-
dients in consumer products. 
A team of researchers now 
reports their observations on 
inhalation exposure through 
the use of nanotechnology-
enabled and non-nanoenabled 
(“regular”)  cosmetic  pow-
ders [EHP 120(6):885–892; 
Nazarenko et al.].
There are currently more 
than  1,300  documented 
nanoenabled consumer prod-
ucts (that is, products that 
incorporate ingredients meas-
uring 1–100 nm in at least 
one dimension). This figure 
represents only those products 
voluntarily reported by manufacturers. In a previous study, these inves-
tigators examined the potential for inhalation of nanoparticles through 
the use of nanoenabled and regular consumer spray products. This 
time, they analyzed particle size, shape, agglomeration (clustering), and 
distribution for three nanoenabled and three regular cosmetic powders. 
To simulate real-world exposures, they applied each powder to a life-size 
female mannequin head using its enclosed brush or pad. Then they 
measured the size distribution and concentration of particles that could 
be inhaled as a result of such application.
All particles in the first sample of nanoenabled powder were in the 
nanoscale range. The second nanoenabled powder contained a wide 
range of agglomerated particles, with the majority being nanosized. 
Despite its label, the third nanoenabled powder contained no nanoscale 
particles. The researchers did find a number of nanoparticles agglomer-
ated with larger particles in two regular powders, which were not 
marketed as nanoenabled. The third regular powder contained mostly 
particles measuring greater 
than 5 mm in diameter.
Particles under 100 nm 
in diameter may travel all the 
way to the terminal alveoli, 
where air exchange takes place. 
However, the authors’ electron 
microscopy data and airborne 
particle measurements suggest 
that exposure to nano  particles 
would  be  largely  through 
agglomerates  of  5–10  mm 
and larger, which are likely to 
lodge in the tracheobronchial 
and head airway regions. But 
because these agglomerates 
have a combined surface area 
greater than that of solid par-
ticles of the same size, they may 
pose different health hazards than solid particles.  
The study offers a methodology that could be applied to future stud-
ies focusing on real-world inhalation exposures related to nanoenabled 
consumer products. Results from such studies can help guide estimates 
of exposures through the short- and long-term use of such products.
Tanya Tillett, MA, of Durham, NC, is a staff writer/editor for EHP. She has been on the EHP staff 
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Nanoparticles in cosmetics 
often cluster into larger 
agglomerations.